Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−18.93 USD
−11.10 M USD
9.93 M USD
653.10 K
About iSpecimen Inc.
Sector
CEO
Tracy Wilson Curley
Website
Headquarters
Woburn
Founded
2009
FIGI
BBG00734QDL2
iSpecimen, Inc. is a healthcare organization that engages in procurement of human biospecimen. It collects biofluids, human tissue, hematopoietic stem, and immune cells. The company was founded by Christopher Ianelli in 2009 and is headquartered in Woburn, MA.
$ISPC entry 14.65-16.15-ish Target PTs 29 and higheriSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and pat
$ISPCiSpecimen, Inc. provides technology that connects life science researchers who need human biofluids, tissues, and living cells for their research with biospecimens available in healthcare provider organizations worldwide. Its cloud-based technology enables researchers to search for specimens and pat
See all ideas
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of ISPC is 4.71 USD — it has increased by 11.26% in the past 24 hours. Watch iSpecimen Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange iSpecimen Inc. stocks are traded under the ticker ISPC.
ISPC stock has risen by 15.69% compared to the previous week, the month change is a 0.82% rise, over the last year iSpecimen Inc. has showed a −60.72% decrease.
ISPC reached its all-time high on Nov 29, 2021 with the price of 579.60 USD, and its all-time low was 3.41 USD and was reached on Oct 30, 2024. View more price dynamics on ISPC chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
ISPC stock is 11.11% volatile and has beta coefficient of −1.56. Track iSpecimen Inc. stock price on the chart and check out the list of the most volatile stocks — is iSpecimen Inc. there?
Today iSpecimen Inc. has the market capitalization of 4.10 M, it has decreased by −18.03% over the last week.
Yes, you can track iSpecimen Inc. financials in yearly and quarterly reports right on TradingView.
iSpecimen Inc. is going to release the next earnings report on Mar 12, 2025. Keep track of upcoming events with our Earnings Calendar.
ISPC earnings for the last quarter are −2.10 USD per share, whereas the estimation was −3.80 USD resulting in a 44.74% surprise. The estimated earnings for the next quarter are −4.00 USD per share. See more details about iSpecimen Inc. earnings.
iSpecimen Inc. revenue for the last quarter amounts to 2.66 M USD, despite the estimated figure of 2.95 M USD. In the next quarter, revenue is expected to reach 2.98 M USD.
ISPC net income for the last quarter is −1.44 M USD, while the quarter before that showed −2.11 M USD of net income which accounts for 31.73% change. Track more iSpecimen Inc. financial stats to get the full picture.
No, ISPC doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 8, 2024, the company has 53.00 employees. See our rating of the largest employees — is iSpecimen Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. iSpecimen Inc. EBITDA is −7.48 M USD, and current EBITDA margin is −91.70%. See more stats in iSpecimen Inc. financial statements.
Like other stocks, ISPC shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade iSpecimen Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So iSpecimen Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating iSpecimen Inc. stock shows the sell signal. See more of iSpecimen Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.